RaolatMAbdulaiMD

Critical Care Medicine

Fellow/Pulmonary and Critical Care Medicine

Dr. Abdulai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2013 - 2016
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2010 - 2013
Howard University College of MedicineClass of 2010

PubMed

Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS).
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, Claus F Vogelmeier, Mona Bafadhel
Respiratory Medicine. 2024-10-30
9 citations
Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension study.
Leonard B Bacharier, Jorge F Maspero, Constance H Katelaris, Alessandro G Fiocchi, Remi Gagnon
The Lancet. Respiratory Medicine. 2024-01-01
2 citations
IL-33 Expression Is Lower in Current Smokers at both Transcriptomic and Protein Levels.
Alen Faiz, Rashad M Mahbub, Fia Sabrina Boedijono, Milan I Tomassen, Wierd Kooistra
American Journal of Respiratory and Critical Care Medicine. 2023-11-15

Beth Israel, Dana-Farber Leaders Offer a Prescription for Better Digital Health: Actionable Data at the Point of CareSeptember 13th, 2019
GMS Sponsors Successful Bio-Diversity Networking EventApril 12th, 2019